Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...

Inactivating the SARS-CoV-2 virus using focused sound waves

A team of researchers from the Ministry of Health in Kuwait has successfully demonstrated the destruction of SARS-CoV-2 virus ...
Infectious Disease Advisor

Updated COVID-19 BNT162b2 KP.2 Vaccine Protective Against Severe Outcomes

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.
University of California, San Francisco

Solving Long COVID: How Decades of HIV Research Paved the Way

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...
Space.com

NASA's Artemis 2 mission: Everything you need to know

Artemis 2 will be the first mission to carry humans to the moon's vicinity since 1972. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Artemis 2 ...